These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21368478)

  • 1. [Role of surgery in treatment of thyroid cancer].
    Sugitani I
    Gan To Kagaku Ryoho; 2011 Feb; 38(2):169-72. PubMed ID: 21368478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
    Shaha AR
    Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma.
    Orita Y; Sugitani I; Matsuura M; Ushijima M; Tsukahara K; Fujimoto Y; Kawabata K
    Surgery; 2010 Mar; 147(3):424-31. PubMed ID: 20176243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of thyroid tumor aggressiveness.
    Clark OH
    West J Med; 1996 Sep; 165(3):131-8. PubMed ID: 8909165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic considerations and operative strategy in papillary thyroid carcinoma: arguments against the routine performance of total thyroidectomy.
    Cohn KH; Bäckdahl M; Forsslund G; Auer G; Zetterberg A; Lundell G; Granberg PO; Löwhagen T; Willems JS; Cady B
    Surgery; 1984 Dec; 96(6):957-71. PubMed ID: 6505969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
    Vassilopoulou-Sellin R; Schultz PN; Haynie TP
    Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prospective therapy study in differentiated thyroid carcinoma].
    Gemsenjäger E; Heitz P; Martina B
    Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Survival potentials of patients with papillary carcinoma of the thyroid gland in Hungary].
    Esik O; Tusnády G; Daubner K; Németh G; Füzy M; Szentirmay Z
    Orv Hetil; 1996 May; 137(20):1067-78. PubMed ID: 8657418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
    Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
    Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
    Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
    Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current diagnostic method, prognosis estimation and therapy of papillary thyroid cancer: recommendations of the medical universities and the National Oncologic Institute of Budapest].
    Esik O; Balázs C; Boér A; Csernay L; Földes J; Füzy M; Horváth OP; Julesz J; Kásler M; Laczi F; Leövey A; Lukács G; Németh G; Perner F; Repa I; Szabolcs I; Szentirmay Z; Trón L; Balázs G
    Orv Hetil; 2000 Jan; 141(1):5-16. PubMed ID: 10673852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the biology and optimal treatment for papillary microcarcinoma of the thyroid?
    Cheema Y; Olson S; Elson D; Chen H
    J Surg Res; 2006 Aug; 134(2):160-2. PubMed ID: 16780882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
    Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
    Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary and follicular thyroid carcinoma.
    Schlumberger MJ; Torlantano M
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):601-13. PubMed ID: 11289737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood and adolescent thyroid carcinoma.
    Grigsby PW; Gal-or A; Michalski JM; Doherty GM
    Cancer; 2002 Aug; 95(4):724-9. PubMed ID: 12209714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of surgery in the management of thyroid cancer.
    Mustard RA
    Can Med Assoc J; 1975 Jul; 113(2):109-13. PubMed ID: 1139493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.